Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Organic Synthesis
  4. Volume 22, Issue 3
  5. Article
Volume 22, Issue 3
  • ISSN: 1570-1794
  • E-ISSN: 1875-6271

Abstract

Background

Given the inadequacies of current chemotherapy, there is a need for more effective anticancer agents. Imidazole and thiazole compounds have demonstrated significant biological activity, making them promising candidates.

Aims and Objectives

This study investigates the anticancer potential of imidazole and thiazole derivatives, focusing on liver cancer. The aim is to synthesize bis-imidazole-thiazole hybrids and evaluate their efficacy as anticancer agents against hepatocellular carcinoma.

Methods

The hybrids were synthesized using (2,2'-((1,4-phenylenebis(2-mercapto-4-methyl-1H-imidazole-1,5-diyl))bis(ethan-1-yl-1-ylidene))bis(hydrazine-1-carbothioamide), hydrazonoyl halides, and α-halo ketones, catalyzed by DABCO. This method is designed to be fast, yield high amounts of product, and be environmentally friendly. Structural confirmation was provided by FT IR, NMR, and MS spectroscopy.

Results

The synthesized hybrids were tested against HepG-2 and WI-38 cell lines. Compounds 16b, 14a, 16a, and 7b showed significant inhibitory activity, with IC values indicating strong inhibition comparable to or better than the standard drug Sorafenib.

Conclusion

The bis-imidazole-thiazole hybrids exhibit potent anticancer properties, particularly against hepatocellular carcinoma, making them potential candidates for future cancer therapies. Their selectivity and safety were further demonstrated by their effects on normal WI-38 human fibroblasts.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cos/10.2174/0115701794310949240607113838
2024-07-02
2025-05-05

  • From This Site

    /content/journals/cos/10.2174/0115701794310949240607113838
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. NagaiH. KimY.H. Cancer prevention from the perspective of global cancer burden patterns.J. Thorac. Dis.20179344845110.21037/jtd.2017.02.7528449441
     [Google Scholar]
  2. BhattP. KumarM. JhaA. Design, synthesis and anticancer evaluation of oxa/thiadiazolylhydrazones of barbituric and thiobarbituric acid: A collective in vitro and in silico approach.ChemistrySelect20183257060706510.1002/slct.201800832
     [Google Scholar]
  3. RashidM. HusainA. MishraR. KarimS. KhanS. AhmadM. Al-wabelN. HusainA. AhmadA. KhanS.A. Design and synthesis of benzimidazoles containing substituted oxadiazole, thiadiazole and triazolo-thiadiazines as a source of new anticancer agents.Arab. J. Chem.20191283202322410.1016/j.arabjc.2015.08.019
     [Google Scholar]
  4. LlovetJ.M. KelleyR.K. VillanuevaA. SingalA.G. PikarskyE. RoayaieS. LencioniR. KoikeK. Zucman-RossiJ. FinnR.S. Hepatocellular carcinoma.Nat. Rev. Dis. Primers202171610.1038/s41572‑020‑00240‑333479224
     [Google Scholar]
  5. IARCCancer Today.2022Available From: https://gco.iarc.fr/
  6. SungH. FerlayJ. SiegelR.L. LaversanneM. SoerjomataramI. JemalA. BrayF. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202171320924910.3322/caac.2166033538338
     [Google Scholar]
  7. ColagrandeS. InghilesiA.L. AburasS. TalianiG.G. NardiC. MarraF. Challenges of advanced hepatocellular carcinoma.World J. Gastroenterol.201622347645765910.3748/wjg.v22.i34.764527678348
     [Google Scholar]
  8. VogelA. CervantesA. ChauI. DanieleB. LlovetJ.M. MeyerT. NaultJ.C. NeumannU. RickeJ. SangroB. SchirmacherP. VerslypeC. ZechC.J. ArnoldD. MartinelliE. ESMO Guidelines Committee Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.Ann. Oncol.201829Suppl. 4iv238iv25510.1093/annonc/mdy30830285213
     [Google Scholar]
  9. KanwalF. KramerJ. AschS.M. ChayanupatkulM. CaoY. El-SeragH.B. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents.Gastroenterology201715349961005.e110.1053/j.gastro.2017.06.01228642197
     [Google Scholar]
  10. EstesC. RazaviH. LoombaR. YounossiZ. SanyalA.J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.Hepatology201867112313310.1002/hep.2946628802062
     [Google Scholar]
  11. AliI. LoneM.N. Aboul-EneinH.Y. Imidazoles as potential anticancer agents.MedChemComm2017891742177310.1039/C7MD00067G30108886
     [Google Scholar]
  12. RaniN. SharmaA. SinghR. Imidazoles as promising scaffolds for antibacterial activity: A review.Mini Rev. Med. Chem.201313121812183510.2174/1389557511313666009124032508
     [Google Scholar]
  13. ZhanP. LiuX. ZhuJ. FangZ. LiZ. PannecouqueC. ClercqE.D. Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.Bioorg. Med. Chem.200917165775578110.1016/j.bmc.2009.07.02819643613
     [Google Scholar]
  14. MishraR. GangulyS. Imidazole as an anti-epileptic: An overview.Med. Chem. Res.201221123929393910.1007/s00044‑012‑9972‑6
     [Google Scholar]
  15. FanY.L. JinX.H. HuangZ.P. YuH.F. ZengZ.G. GaoT. FengL.S. Recent advances of imidazole-containing derivatives as anti-tubercular agents.Eur. J. Med. Chem.201815034736510.1016/j.ejmech.2018.03.01629544148
     [Google Scholar]
  16. RaniN. SharmaA. GuptaG. SinghR. Imidazoles as potential antifungal agents: A review.Mini Rev. Med. Chem.201313111626165510.2174/1389557511313999006923815583
     [Google Scholar]
  17. SharmaP. LaRosaC. AntwiJ. GovindarajanR. WerbovetzK.A. Imidazoles as potential anticancer agents: An update on recent studies.Molecules20212614421310.3390/molecules2614421334299488
     [Google Scholar]
  18. AliI. LoneM. Al-OthmanZ. Al-WarthanA. SanagiM. Heterocyclic scaffolds: Centrality in anticancer drug development.Curr. Drug Targets201516771173410.2174/138945011666615030911592225751009
     [Google Scholar]
  19. FranchettiP. CappellacciL. GrifantiniM. BarziA. NocentiniG. YangH. O’ConnorA. JayaramH.N. CarrellC. GoldsteinB.M. Furanfurin and thiophenfurin: Two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.J. Med. Chem.199538193829383710.1021/jm00019a0137562914
     [Google Scholar]
  20. LiX. HeY. RuizC.H. KoenigM. CameronM.D. VojkovskyT. Characterization of dasatinib and its structural analogs as CYP3A4 mechanism-based inactivators and the proposed bioactivation pathways.Drug Metab. Dispos.20093761242125010.1124/dmd.108.02593219282395
     [Google Scholar]
  21. Hu-LieskovanS. MokS. Homet MorenoB. TsoiJ. RobertL. GoedertL. PinheiroE.M. KoyaR.C. GraeberT.G. Comin-AnduixB. RibasA. Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF V600E melanoma.Sci. Transl. Med.20157279279ra4110.1126/scitranslmed.aaa469125787767
     [Google Scholar]
  22. YaoY. ChenS. ZhouX. XieL. ChenA. 5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cells.Oncol. Lett.20147254154710.3892/ol.2013.169724396484
     [Google Scholar]
  23. AltmannK.H. Epothilone B and its analogs - a new family of anticancer agents.Mini Rev. Med. Chem.20033214915810.2174/138955703340526912570848
     [Google Scholar]
  24. SharmaP.C. BansalK.K. SharmaA. SharmaD. DeepA. Thiazole-containing compounds as therapeutic targets for cancer therapy.Eur. J. Med. Chem.202018811201610.1016/j.ejmech.2019.11201631926469
     [Google Scholar]
  25. AliabadiA. ShamsaF. OstadS.N. EmamiS. ShafieeA. DavoodiJ. ForoumadiA. Synthesis and biological evaluation of 2-phenylthiazole-4-carboxamide derivatives as anticancer agents.Eur. J. Med. Chem.201045115384538910.1016/j.ejmech.2010.08.06320846760
     [Google Scholar]
  26. AyatiA. EmamiS. AsadipourA. ShafieeA. ForoumadiA. Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery.Eur. J. Med. Chem.20159769971810.1016/j.ejmech.2015.04.01525934508
     [Google Scholar]
  27. SayedA.R. GomhaS.M. TaherE.A. MuhammadZ.A. El-SeediH.R. GaberH.M. AhmedM.M. One-pot synthesis of novel thiazoles as potential anti-cancer agents.Drug Des. Devel. Ther.2020141363137510.2147/DDDT.S22126332308369
     [Google Scholar]
  28. DasD. SikdarP. BairagiM. Recent developments of 2-aminothiazoles in medicinal chemistry.Eur. J. Med. Chem.2016109899810.1016/j.ejmech.2015.12.02226771245
     [Google Scholar]
  29. RamadanE. HamidH.M. NoureddinS.A. BadahdahK.O. Synthesis, characterization, and antitumor activity of some novel S-functionalized benzo[d]thiazole-2-thiol derivatives; regioselective coupling to the eSH group.J. Chem. Sci.201873647654
     [Google Scholar]
  30. MorigiR. LocatelliA. LeoniA. RambaldiM. Recent patents on thiazole derivatives endowed with antitumour activity. Recent Pat. Anti-Cancer Drug Discov201510328029726152151
     [Google Scholar]
  31. HeH. WangX. ShiL. YinW. YangZ. HeH. LiangY. Synthesis, antitumor activity and mechanism of action of novel 1,3-thiazole derivatives containing hydrazide–hydrazone and carboxamide moiety.Bioorg. Med. Chem. Lett.201626143263327010.1016/j.bmcl.2016.05.05927262600
     [Google Scholar]
  32. ShaikS.P. NayakV.L. SultanaF. RaoA.V.S. ShaikA.B. BabuK.S. KamalA. Design and synthesis of imidazo[2,1-b]thiazole linked triazole conjugates: Microtubule-destabilizing agents.Eur. J. Med. Chem.2017126365110.1016/j.ejmech.2016.09.06027744185
     [Google Scholar]
  33. GomhaS. EdreesM. MuhammadZ. El-ReedyA. 5-(Thiophen-2-yl)-1,3,4-thiadiazole derivatives: Synthesis, molecular docking and in vitro cytotoxicity evaluation as potential anticancer agents.Drug Des. Devel. Ther.2018121511152310.2147/DDDT.S16527629881258
     [Google Scholar]
  34. AlshabanahL.A. Al-MutabaganiL.A. GomhaS.M. AhmedH.A. Three-component synthesis of some new coumarin derivatives as anti-cancer agents.Front Chem.2022976224810.3389/fchem.2021.76224835145952
     [Google Scholar]
  35. Abu-MelhaS. EdreesM.M. RiyadhS.M. AbdelazizM.R. ElfikyA.A. GomhaS.M. Clean grinding technique: A facile synthesis and in silico antiviral activity of hydrazones, pyrazoles, and pyrazines bearing thiazole moiety against SARS-CoV-2 main protease (Mpro).Molecules20202519456510.3390/molecules2519456533036293
     [Google Scholar]
  36. XuZ. ZhaoS.J. LvZ.S. GaoF. WangY. ZhangF. BaiL. DengJ.L. Fluoroquinolone-isatin hybrids and their biological activities.Eur. J. Med. Chem.201916239640610.1016/j.ejmech.2018.11.03230453247
     [Google Scholar]
  37. BhoiM.N. BoradM.A. SolankiA.P. PatelH.D. Novel 4 H -pyrimido[2,1-b]benzothiazoles derivatives: Camphorsulphonic acid catalyzed enantioselective synthesis, optimization, and biological study.Phosphorus Sulfur Silicon Relat. Elem.202319810822835[REMOVED HYPERLINK FIELD].10.1080/10426507.2023.2199994
     [Google Scholar]
  38. JethavaD.J. BoradM.A. BhoiM.N. AcharyaP.T. BhavsarZ.A. PatelH.D. New dimensions in triazolo[4,3-a]pyrazine derivatives: The land of opportunity in organic and medicinal chemistry.Arab. J. Chem.202013128532859110.1016/j.arabjc.2020.09.038
     [Google Scholar]
  39. BhoiM.N. BoradM.A. PithawalaE.A. PatelH.D. Novel benzothiazole containing 4H-pyrimido[2,1-b]benzothiazoles derivatives: One pot, solvent-free microwave assisted synthesis and their biological evaluation.Arab. J. Chem.20191283799381310.1016/j.arabjc.2016.01.012
     [Google Scholar]
  40. ChakrabortyN. MitraA.K. The versatility of DABCO as a reagent in organic synthesis: A review.Org. Biomol. Chem.202321346830688010.1039/D3OB00921A37605948
     [Google Scholar]
  41. JangidD.K. DABCO as a base and an organocatalyst in organic synthesis: A review.Curr. Green Chem.20207214616210.2174/2213346107666191227101538
     [Google Scholar]
  42. BosicaG. AbdillaR. DABCO-Amberlyst®15: A versatile heterogeneous catalyst in the multicomponent synthesis of tetrahydronaphthalenes and tetrahydroquinolines.Tetrahedron Green Chem20243100033
     [Google Scholar]
  43. GomhaS.M. BadreyM.G. ArafaW.A.A. DABCO-catalyzed green synthesis of thiazole and 1,3-thiazine derivatives linked to benzofuran.Heterocycles2016921450146110.3987/COM‑16‑13470
     [Google Scholar]
  44. IshtiaqM. KhanM.A. AhmedS. AliS. al-RashidaM. IftikharS. MoinS.T. HameedA. Probing new DABCO-F based ionic liquids as catalyst in organic synthesis.J. Mol. Struct.2022126813363810.1016/j.molstruc.2022.133638
     [Google Scholar]
  45. FeyT. FischerH. BachmannS. AlbertK. BolmC. Silica-supported TEMPO catalysts: Synthesis and application in the Anelli oxidation of alcohols.J. Org. Chem.200166248154815910.1021/jo010535q11722219
     [Google Scholar]
  46. GomhaS.M. AbdelazizM.R. KhederN.A. Abdel-azizH.M. AlteraryS. MabkhotY.N. A facile access and evaluation of some novel thiazole and 1,3,4-thiadiazole derivatives incorporating thiazole moiety as potent anticancer agents.Chem. Cent. J.201711110510.1186/s13065‑017‑0335‑829086869
     [Google Scholar]
  47. Al-HumaidiJ.Y. AlbedairL.A. FaragB. ZakiM.E.A. MukhrishY.E. GomhaS.M. Design and synthesis of novel hybrids incorporating thiadiazole or thiazole-naphthalene: Anticancer assessment and molecular docking study.Results in Chemistry2024710147510.1016/j.rechem.2024.101475
     [Google Scholar]
  48. AfifiT.H. RiyadhS.M. DeawalyA.A. NaqviA. Novel chromenes and benzochromenes bearing arylazo moiety: Molecular docking, in-silico admet, in-vitro antimicrobial and anticancer screening.Med. Chem. Res.20192891471148710.1007/s00044‑019‑02387‑5
     [Google Scholar]
  49. GomhaS. AbdallahM. Abd El-AzizM. SeragN. Ecofriendly one-pot synthesis and antiviral evaluation of novel pyrazolyl pyrazolines of medicinal interest.Turk. J. Chem.20164048449810.3906/kim‑1510‑25
     [Google Scholar]
  50. OufS.A. GomhaS.M. FaragB. ZakiM.E.A. EwiesM.M. SharawyI.A.A. KhalilF.O. MahmoudH.K. Synthesis of novel Bis-1,2,4-Triazolo[3,4-b][1,3,4]Thiadiazines from natural camphoric acid as potential anti-candidal agents.Results in Chemistry2024710140610.1016/j.rechem.2024.101406
     [Google Scholar]
  51. IbrahimM. FaragB. Al-HumaidiJ. ZakiM. FathallaM. GomhaS. Mechanochemical synthesis and molecular docking studies of new azines bearing indole as anticancer agents.Molecules2023289386910.3390/molecules2809386937175279
     [Google Scholar]
  52. SayedA.R. GomhaS.M. Abd El-lateefH.M. AbolibdaT.Z. L-proline catalyzed green synthesis and anticancer evaluation of novel bioactive benzil bis-hydrazones under grinding technique.Green Chem. Lett. Rev.202114218018910.1080/17518253.2021.1893392
     [Google Scholar]
  53. GomhaS.M. AbdelazizM.R. Abdel-AzizH.M. HassanS.A. Green synthesis and molecular docking of thiazolyl-thiazole derivatives as potential cytotoxic agents.Mini Rev. Med. Chem.201717980581510.2174/138955751666616122315453928019641
     [Google Scholar]
  54. GomhaS.M. MuhammadZ.A. El-ReedyA.A.M. Intramolecular ring transformation of bis-oxadiazoles to bis-thiadiazoles and investigation of their anticancer activities.J. Heterocycl. Chem.201855102360236710.1002/jhet.3300
     [Google Scholar]
  55. Al-MutabaganiL.A. AbdelrazekF.M. GomhaS.M. HebishyA.S. AbdelfattahM.S. HassanS.M. SayedA.R. ElaasserM.M. Synthesis and biological evaluation of thiazolyl-ethylidene hydrazino-thiazole derivatives: A novel heterocyclic system.Appl. Sci.20211119890810.3390/app11198908
     [Google Scholar]
  56. EdreesM. MelhaS. SaadA. KhederN. GomhaS. MuhammadZ. Eco-Friendly synthesis, characterization and biological evaluation of some novel pyrazolines containing thiazole moiety as potential anticancer and antimicrobial agents.Molecules20182311297010.3390/molecules2311297030441815
     [Google Scholar]
  57. DhawasA.K. ThakareS.S. ThakareN.R. Synthesis and characterization of some new 1, 4, 5-trisubstituted imidazole-2-thiols derivatives.J. Chem. Pharm. Res.20124866871
     [Google Scholar]
  58. El-EnanyW.A.M.A. GomhaS.M. El-ZiatyA.K. HusseinW. AbdullaM.M. HassanS.A. SallamH.A. AliR.S. Synthesis and molecular docking of some new bis-thiadiazoles as antihypertensive α-blocking agents.Synth. Commun.2019112
     [Google Scholar]
  59. AlshabanahL.A. GomhaS.M. Al-MutabaganiL.A. AbolibdaT.Z. Abd El-GhanyN.A. El-EnanyW.A.M.A. El-ZiatyA.K. AliR.S. MohamedN.A. Cross-linked chitosan/multi-walled carbon nanotubes composite as ecofriendly biocatalyst for synthesis of some composite as ecofriendly biocatalyst for synthesis of some novel benzil bis-thiazoles.Polymers202113172810.3390/polym1311172834070526
     [Google Scholar]
  60. MahmoudH.K. AbbasA.A. GomhaS.M. Synthesis, antimicrobial evaluation and molecular docking of new functionalized bis(1,3,4-thiadiazole) and bis(thiazole) derivatives.Polycycl. Aromat. Compd.20214192029204110.1080/10406638.2019.1709085
     [Google Scholar]
  61. GomhaS. KhederN. AbdelhamidA. MabkhotY. One pot single step synthesis and biological evaluation of some novel bis(1,3,4-thiadiazole) derivatives as potential cytotoxic agents.Molecules20162111153210.3390/molecules2111153227854300
     [Google Scholar]
  62. MuhammadZ.A. MasaretG.S. AminM.M. AbdallahM.A. FarghalyT.A. Anti-inflammatory, analgesic and anti-ulcerogenic activities of novel bis-thiadiazoles, bis-thiazoles and bis-formazanes.Med. Chem.201713322623810.2174/157340641266616092009114627659119
     [Google Scholar]
  63. KassabR.M. GomhaS.M. Al-HussainS.A. Abo DenaA.S. Abdel-AzizM.M. ZakiM.E.A. MuhammadZ.A. Synthesis and in-silico simulation of some new bis-thiazole derivatives and their preliminary antimicrobial profile: Investigation of hydrazonoyl chloride addition to hydroxy-functionalized bis-carbazones.Arab. J. Chem.2021141110339610.1016/j.arabjc.2021.103396
     [Google Scholar]
  64. GomhaS.M. BadreyM.G. EdreesM.M. Heterocyclization of a bis-thiosemicarbazone of 2,5-diacetyl-3,4-disubstituted-thieno[2,3-b]thiophene bis-1,4-phenylene-bis-thiazole derivatives and bis-1,3,4-thiadiazoles as anti-breast cancer agents.J. Chem. Res.20164012012510.3184/174751916X14537182696214
     [Google Scholar]
  65. ShawaliA.S. GomhaS.M. Regioselectivity in 1,5-electrocyclization of N-[as-triazin-3-yl]nitrilimines. Synthesis of s-triazolo[4,3-b]-as-triazin-7(8H)-ones.Tetrahedron200258428559856410.1016/S0040‑4020(02)00946‑8
     [Google Scholar]
  66. BadreyM.G. GomhaS.M. 3-Amino-8-hydroxy-4-imino-6-methyl-5-phenyl-4,5-dihydro-3H-chromeno [2,3-d]pyrimidine: An effecient key precursor for novel synthesis of some interesting triazines and triazepines as potential anti-tumor agents.Molecules20121710115381155310.3390/molecules17101153823018926
     [Google Scholar]
  67. AbbasI.M. RiyadhS.M. AbdallahM.A. GomhaS.M. A novel route to tetracyclic fused tetrazines and thiadiazines.J. Heterocycl. Chem.200643493594210.1002/jhet.5570430419
     [Google Scholar]
/content/journals/cos/10.2174/0115701794310949240607113838
Loading
Green Synthesis and Anticancer Activity of New Bis-imidazole-thiazole Hybrids Targeting Hepatocellular Carcinoma
Curr. Org. Synth. 22, 371 (2025); https://doi.org/10.2174/0115701794310949240607113838
/content/journals/cos/10.2174/0115701794310949240607113838
/content/journals/cos/10.2174/0115701794310949240607113838
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): anticancer; bis-imidazoles; Bis-thiazoles; DABCO; hydrazonoyl halides; thiosemicarbazones

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test